Supplement

Form 8.3 - The Vanguard Group, Inc.: Hibernian REIT plc

Retrieved on: 
Tuesday, May 17, 2022 - 3:54pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Health

Retrieved on: 
Tuesday, May 17, 2022 - 2:30pm

[1],[2] Peer-reviewed, clinical evidence shows this breakthrough has the power to transform how we detect, prevent, and treat pregnancy complications.

Key Points: 
  • [1],[2] Peer-reviewed, clinical evidence shows this breakthrough has the power to transform how we detect, prevent, and treat pregnancy complications.
  • At Mirvie, we find it unacceptable that pregnancy health has not advanced meaningfully in decades, said Maneesh Jain, Co-Founder and CEO of Mirvie.
  • We believe the Mirvie RNA platform can shape a new future of predictive, preventive, and personalized pregnancy care for the well-being of millions of expecting parents and babies.
  • Mirvie is shaping the future of pregnancy health by providing women, expecting parents and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis.

RBB Bancorp Files Supplement to Proxy Statement

Retrieved on: 
Monday, May 16, 2022 - 9:05pm

RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that the Company has filed with the Securities and Exchange Commission a Supplement to the Companys Proxy Statement that was distributed on or about April 18, 2022 that provides updated information with respect to the Annual Meeting of Shareholders (the Annual Meeting) of RBB Bancorp (the Company) to be held on Wednesday, May 18, 2022.

Key Points: 
  • RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that the Company has filed with the Securities and Exchange Commission a Supplement to the Companys Proxy Statement that was distributed on or about April 18, 2022 that provides updated information with respect to the Annual Meeting of Shareholders (the Annual Meeting) of RBB Bancorp (the Company) to be held on Wednesday, May 18, 2022.
  • RBB Bancorp is a community-based financial holding company headquartered in Los Angeles, California.
  • As of March 31, 2022, the company had total assets of $4.0 billion.
  • There can be no assurance that other factors not currently anticipated by RBB will not materially and adversely affect its business, financial condition and results of operations.

Lincoln Financial expands Indexed Universal Life suite with survivorship product for wealth transfer and estate planning

Retrieved on: 
Monday, May 16, 2022 - 2:10pm

Lincoln Financial Group (NYSE:LNC) today launched Lincoln WealthPreserve2 Survivorship Indexed Universal Life (SIUL) for couples or business partners looking to insure two individuals in a single policy.

Key Points: 
  • Lincoln Financial Group (NYSE:LNC) today launched Lincoln WealthPreserve2 Survivorship Indexed Universal Life (SIUL) for couples or business partners looking to insure two individuals in a single policy.
  • If properly structured in an irrevocable trust, the life insurance proceeds from Lincoln WealthPreserve2 SIUL may also be free from estate taxes.
  • Financial professionals can play an important role in developing goals-based estate planning strategies on behalf of clients and helping them understand the flexibility that survivorship products like Lincoln WealthPreserve2 SIUL bring to the process.
  • Headquartered in Radnor, Pennsylvania, Lincoln Financial Group is the marketing name for Lincoln National Corporation (NYSE:LNC) and its affiliates.

Form 8.3 - The Vanguard Group, Inc.: Hibernian REIT plc

Retrieved on: 
Friday, May 13, 2022 - 2:14pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Hibernian REIT plc

Retrieved on: 
Thursday, May 12, 2022 - 2:58pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

WELL Health Announces $30 Million Bought Deal Offering of Common Shares

Retrieved on: 
Wednesday, May 11, 2022 - 9:55pm

VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- WELL Health Technologies Corp. (TSX: WELL) (“WELL” or the “Company”) is pleased to announce that it has entered into an agreement pursuant to which Eight Capital and Stifel GMP as joint bookrunners and co-lead underwriters, together with a syndicate of underwriters (collectively, the “Underwriters”), will purchase, on a bought deal basis, 8,109,000 common shares in the capital of the Company (the “Shares”), subject to all regulatory approvals, at a price of $3.70 per Share (the “Issue Price”) for gross proceeds of $30,003,300 (the “Offering”).

Key Points: 
  • If this option is exercised in full, approximately $4,500,000 additional proceeds will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be approximately $34,500,000.
  • The Company has received indications of interest for lead orders in connection with the Offering from a large International Sovereign Wealth Fund and Hong Kong businessman and investor Mr. Li Ka-shing.
  • WELLs earnings and cash flow continues to grow, and our business continues to mature as we complete the optimization and integration of businesses acquired in 2021.
  • The Base Prospectus and, once filed, the Supplement can be found on SEDAR at www.sedar.com , and contain important detailed information about the Offering.

Form 8.3 - The Vanguard Group, Inc.: Hibernian REIT plc

Retrieved on: 
Tuesday, May 10, 2022 - 2:31pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

South Africa and Global Supplements Market Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 5, 2022 - 3:48pm

The "South African Supplements Industry Landscape Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "South African Supplements Industry Landscape Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • For the Global Supplements Industry Section:
    What are the current market dynamics of the Global Supplements industry?
  • For the South African Supplements Manufacturer & Distributor Section:
    Which are the key manufacturing and distributor players in the South African Supplements industry?
  • For the South African Supplements Retail and Pricing Analysis Section:
    Which are the key retail players (retail house brands) in the South African Supplements industry?

Form 8.3 - The Vanguard Group, Inc.: Hibernian REIT plc Revised

Retrieved on: 
Thursday, May 5, 2022 - 3:16pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO